Ningbo David Medical Device Co., Ltd.

SZSE:300314 Stock Report

Market Cap: CN¥3.4b

Ningbo David Medical Device Future Growth

Future criteria checks 5/6

Ningbo David Medical Device is forecast to grow earnings and revenue by 42% and 30.2% per annum respectively. EPS is expected to grow by 41.9% per annum. Return on equity is forecast to be 18.4% in 3 years.

Key information

42.0%

Earnings growth rate

41.9%

EPS growth rate

Medical Equipment earnings growth26.6%
Revenue growth rate30.2%
Future return on equity18.4%
Analyst coverage

Low

Last updated29 Apr 2024

Recent future growth updates

No updates

Recent updates

Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Oct 30
Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%

Sep 27
Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%

Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely

May 22
Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely

Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Apr 26
Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story

Mar 06
Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story

Earnings and Revenue Growth Forecasts

SZSE:300314 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,224328N/A3051
12/31/2025981251N/A2301
12/31/2024780201N/A1671
9/30/202456288-4979N/A
6/30/2024567102-1396N/A
3/31/202461613646118N/A
12/31/202361814895135N/A
9/30/2023615144107156N/A
6/30/202361415388146N/A
3/31/202356613885136N/A
1/1/20235069762112N/A
9/30/20224988980105N/A
6/30/202248149109114N/A
3/31/2022477688187N/A
1/1/2022474804551N/A
9/30/2021469777688N/A
6/30/20214821466487N/A
3/31/202147814487110N/A
12/31/2020460136114138N/A
9/30/202043614882102N/A
6/30/20203989995104N/A
3/31/2020366678493N/A
12/31/2019356627989N/A
9/30/2019341327181N/A
6/30/2019310235364N/A
3/31/2019300245769N/A
12/31/2018300295570N/A
9/30/2018287342743N/A
6/30/201829034N/A44N/A
3/31/201829542N/A42N/A
12/31/201730447N/A56N/A
9/30/201730365N/A70N/A
6/30/201729669N/A69N/A
3/31/201727964N/A72N/A
12/31/201626562N/A77N/A
9/30/201623757N/A64N/A
6/30/201622249N/A51N/A
3/31/201622146N/A44N/A
12/31/201521945N/A48N/A
9/30/201522553N/A50N/A
6/30/201522353N/A56N/A
3/31/201523055N/A74N/A
12/31/201422754N/A68N/A
9/30/201422754N/A63N/A
6/30/201421855N/A63N/A
3/31/201420957N/A48N/A
12/31/201321764N/A56N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300314's forecast earnings growth (42% per year) is above the savings rate (2.8%).

Earnings vs Market: 300314's earnings (42% per year) are forecast to grow faster than the CN market (26.1% per year).

High Growth Earnings: 300314's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300314's revenue (30.2% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300314's revenue (30.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300314's Return on Equity is forecast to be low in 3 years time (18.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y